Breaking down barriers: The potential of smarter CAR-engineered NK cells against solid tumors.

导出 LinkOut

翻译打印收藏纠错

作者： Muhammad B,Khawar ^[1] ; Guangzhong,Gao ^[2] ; Mussarat,Rafiq ^[3] ; Anila,Shehzadi ^[4] ; Ali,Afzal ^[5] ; Muddasir H,Abbasi ^[6] ; Nadeem,Sheikh ^[6] ; Nimra,Afzal ^[7] ; Muhammad A,Ashraf ^[5] ; Syeda E,Hamid ^[6] ; Sara,Shahzaman ^[8] ; Naseer,Kawish ^[6] ; Haibo,Sun ^[6]

作者单位： Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, China. ^[1] Jiangsu Key Laboratory of Experimental and, Translational Noncoding RNA Research, Yangzhou, China. ^[2] Department of Zoology, Applied Molecular Biology and Biomedicine Lab, University of Narowal, Narowal, Pakistan. ^[3] Department of Physiatry, Haian Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nantong, Jiangsu, China. ^[4] Cell & Molecular Biology Lab, Institute of Zoology, University of the Punjab, Lahore, Pakistan. ^[5] Department of Zoology, Molecular Medicine and Cancer Therapeutics Lab, University of Central Punjab, Lahore, Pakistan. ^[6] Department of Zoology, University of Okara, Punjab, Pakistan. ^[7] Department of Zoology, University of Education, Lahore, Pakistan. ^[8]

关键词 CAR-NK cell immunotherapy preclinical and clinical studies preference over CAR-T immunotherapy

主题词人类(Humans);杀伤细胞, 天然(Killer Cells, Natural);肿瘤(Neoplasms);免疫疗法, 过继(Immunotherapy, Adoptive);免疫疗法(Immunotherapy)

DOI 10.1002/jcb.30460

PMID 37566723

发布时间 2023-08-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交